Pay in 4 interest-free payments of $5.44 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
However, women who are pregnant, breastfeeding, or planning pregnancy should avoid 5-amino-1MQ due to insufficient safety data
Dosing Schedules from Published Research Phase 2 Trial Dose Groups The Phase 2 clinical trial published in NEJM employed the following dose groups, all administered via subcutaneous injection once weekly: Scroll sideways to view the full table on mobile
BPC-157 is a synthetic 15-residue peptide with the sequence GEPPPGKPADDAGLV
benefits Outside groups have echoed the concerns raised by the agency's career scientists
Gastrointestinal Protection Multiple studies showed cytoprotective effects against: NSAID-induced gastric lesions Alcohol-induced mucosal damage Reference: Sikiric et al., 2013 BPC 157 in Research Stacks (Wolverine Stack) Within research communities, BPC-157 peptides are sometimes grouped with TB-500 in what is informally referred to as the wolverine stack. This terminology reflects: Observed tissue repair activity Angiogenic support Regenerative properties in animal models It is not a medical classification, but rather research shorthand
